Connexin over-expression differentially suppresses glioma growth and contributes to the bystander effect following HSV-thymidine kinase gene therapy

Cell Communication and Adhesion

Volumn 13, Issue 1-2, 2006, Pages 79-92

  Jimenez, Tomas ^a   Fox, W Paul ^a   Naus, Christian C G ^b   Galipeau, Jacques ^c   Belliveau, Daniel J ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Bystander effect; Connexin; Gap junction; Gene therapy; Glioma; Thymidine kinase

Indexed keywords

ACICLOVIR; CONNEXIN 26; CONNEXIN 32; CONNEXIN 43; GANCICLOVIR; GREEN FLUORESCENT PROTEIN; RETROVIRUS VECTOR; THYMIDINE KINASE;

ANIMAL CELL; ARTICLE; BYSTANDER EFFECT; CANCER INHIBITION; CELL DEATH; COCULTURE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENTIATION; GAP JUNCTION; GENE OVEREXPRESSION; GENETIC TRANSDUCTION; GLIOMA; HERPES SIMPLEX VIRUS; NONHUMAN; PRIORITY JOURNAL; RAT; SUICIDE GENE THERAPY; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

BYSTANDER EFFECT; CELL SURVIVAL; COCULTURE TECHNIQUES; CONNEXIN 43; CONNEXINS; GANCICLOVIR; GAP JUNCTIONS; GENE THERAPY; GENES, TRANSGENIC, SUICIDE; GLIOMA; HERPESVIRUS 1, HUMAN; HUMANS; PRODRUGS; THYMIDINE KINASE; TUMOR CELLS, CULTURED;

ANIMALIA; SIMPLEXVIRUS;

EID: 33646078796     PISSN: 10615385     EISSN: 15435180     Source Type: Journal    
DOI: 10.1080/15419060600631771     Document Type: Article

References (56)

1. Belliveau, D and Bechberger, J and Rogers, K and Naus, C. (1997) Differential expression of gap junctions in neurons and astrocytes derived from p19 embryonal carcinoma cells Dev Genet, 21, pp. 187-200. [PUBMED] [CSA]
2. Beyer, E and Paul, D and Goodenough, D. (1987) Connexin43: A protein from rat heart homologous to a gap junction protein from liver J Cell Biol, 105, pp. 2621-2629. [PUBMED] [CSA]
3. Bi, W and Parysek, L and Warnick, R and Stambrook, P. (1993) In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy Hum Gene Ther, 4, pp. 725-731. [PUBMED] [CSA]
4. Bond, S and Bechberger, J and Khoo, N and Naus, C. (1994) Transfection of C6 glioma cells with connexin32: The effects of expression of a nonendogenous gap junction protein Cell Growth Differ, 5, pp. 179-186. [PUBMED] [CSA]
5. Bruzzone, R and White, T and Paul, D. (1996) Connections with connexins: The molecular basis of direct intercellular signaling Eur J Biochem, 238, pp. 1-27. [PUBMED] [CSA]
6. Burrows, F and Gore, M and Smiley, W and Kanemitsu, M and Jolly, D and Read, S and Nicholas, T and Kruse, C. (2002) Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells Cancer Gene Ther, 9, pp. 87-95. [PUBMED] [CSA]
7. Carrió, M and Mazo, M and López-Iglesias, C and Estivill, X and Fillat, C. (2001) Retrovirus-mediated transfer of the herpes simplex virus thymidine kinase and connexin26 genes in pancreatic cells results in variable efficiency on the bystander killing: Implications for gene therapy Int J Cancer, 94, pp. 81-88. [CSA]
8. Carystinos, G and Katabi, M and Laird, D and Galipeau, J and Chan, H and Alaoui-Jamali, M and Batist, G. (1999) Cyclic-AMP induction of gap junctional intercellular communication increases bystander effect in suicide gene therapy Clin Cancer Res, 5, pp. 61-68. [PUBMED] [CSA]
9. Cirenei, N and Colombo, B and Mesnil, M and Benedetti, S and Yamasaki, H and Finocchiaro, G. (1998) In vitro and in vivo effects of retrovirus-mediated transfer of the connexin 43 gene in malignant gliomas: Consequences for HSVtk/GCV anticancer gene therapy Gene Ther, 5, pp. 1221-1226. [PUBMED] [CSA]
10. Dilber, M and Abedi, M and Christensson, B and Bjorkstrand, B and Kidder, G and Naus, C and Gahrton, G and Smith, C. (1997) Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo Cancer Res, 57, pp. 1523-1528. [PUBMED] [CSA]
11. Eghbali, B and Kessler, J and Reid, L and Roy, C and Spray, D. (1991) Involvement of gap junctions in tumorigenesis: Transfection of tumor cells with connexin 32 cDNA retards growth in vivo Proc Natl Acad Sci U S A, 88, pp. 10701-10705. [PUBMED] [CSA]
12. Estin, D and Li, M and Spray, D and Wu, J. (1999) Connexins are expressed in primary brain tumors and enhance the bystander effect in gene therapy Neurosurgery, 44, pp. 361-368. discussion 368-369 [PUBMED] [CSA]
13. Freeman, S and Abboud, C and Whartenby, K and Packman, C and Koeplin, D and Moolten, F and Abraham, G. (1993) The "bystander effect": Tumor regression when a fraction of the tumor mass is genetically modified Cancer Res, 53, pp. 5274-5283. [PUBMED] [CSA]
14. Galipeau, J and Li, H and Paquin, A and Sicilia, F and Karpati, G and Nalbantoglu, J. (1999) Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer Cancer Res, 59, pp. 2384-2394. [PUBMED] [CSA]
15. Gemel, J and Valiunas, V and Brink, P and Beyer, E. (2004) Connexin43 and connexin26 form gap junctions, but not heteromeric channels in co-expressing cells J Cell Sci, 117, pp. 2469-2480. [PUBMED] [CSA]
16. Ghoumari, A and Mouawad, R and Zerrouqi, A and Nizard, C and Provost, N and Khayat, D and Naus, C and Soubrane, C. (1998) Actions of HSVtk and connexin43 gene delivery on gap junctional communication and drug sensitization in hepatocellular carcinoma Gene Ther, 5, pp. 1114-1121. [PUBMED] [CSA]
17. Goldberg, G and Bechberger, J and Naus, C. (1995) A pre-loading method of evaluating gap junctional communication by fluorescent dye transfer Biotechniques, 18, pp. 490-497. [PUBMED] [CSA]
18. Hellmann, P and Grummer, R and Schirrmacher, K and Rook, M and Traub, O and Winterhager, E. (1999) Transfection with different connexin genes alters growth and differentiation of human choriocarcinoma cells Exp Cell Res, 246, pp. 480-490. [PUBMED] [CSA]
19. Ishii-Morita, H and Agbaria, R and Mullen, C and Hirano, H and Koeplin, D and Ram, Z and Oldfield, E and Johns, D and Blaese, R. (1997) Mechanism of 'bystander effect' killing in the herpes simplex thymidine kinase gene therapy model of cancer treatment Gene Ther, 4, pp. 244-251. [PUBMED] [CSA]
20. Kew, Y and Levin, V. (2003) Advances in gene therapy and immunotherapy for brain tumors Curr Opin Neurol, 16, pp. 665-670. [PUBMED] [CSA]
21. Kirn, D and Niculescu-Duvaz, I and Hallden, G and Springer, C. (2002) The emerging fields of suicide gene therapy and virotherapy Trends Mol Med, 8, pp. S68-S73. [PUBMED] [CSA]
22. Lagree, V and Brunschwig, K and Lopez, P and Gilula, N and Richard, G and Falk, M. (2003) Specific amino-acid residues in the N-terminus and TM3 implicated in channel function and oligomerization compatibility of connexin43 J Cell Sci, 116, pp. 3189-3201. [PUBMED] [CSA]
23. Lee, H and Lee, I and Seul, K and Rhee, S. (2002) Growth inhibition by connexin26 expression in cultured rodent tumor cells Mol Cells, 14, pp. 136-142. [PUBMED] [CSA]
24. Lonardi, S and Tosoni, A and Brandes, A. (2005) Adjuvant chemotherapy in the treatment of high grade gliomas Cancer Treat Rev, 31, pp. 79-89. [PUBMED] [CSA]
25. Mao, J and Bechberger, J and Galipeau, J and Naus, C. (2000) The effect of retrovirus mediated connexin43 overexpression in neuro-2a cells on neuronal differentiation J Biol Chem, 275, pp. 34407-34414. [PUBMED] [CSA]
26. Marconi, P and Tamura, M and Moriuchi, S and Krisky, D and Niranjan, A and Goins, W and Cohen, J and Glorioso, J. (2000) Connexin 43-enhanced suicide gene therapy using herpesviral vectors Mol Ther, 1, pp. 71-81. [PUBMED] [CSA]
27. Mesnil, M. (2002) Connexins and cancer Biol Cell, 94, pp. 493-500. [PUBMED] [CSA]
28. Mesnil, M and Krutovskikh, V and Piccoli, C and Elfgang, C and Traub, O and Willecke, K and Yamasaki, H. (1995) Negative growth control of HeLa cells by connexin genes: Connexin species specificity Cancer Res, 55, pp. 629-639. [PUBMED] [CSA]
29. Mitchell, P and Ellison, D and Mendelow, A. (2005) Surgery for malignant gliomas: Mechanistic reasoning and slippery statistics Lancet Neurol, 4, pp. 413-422. [PUBMED] [CSA]
30. Moolten, F. (1986) Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy Cancer Res, 46, pp. 5276-5281. [PUBMED] [CSA]
31. Namba, H and Iwadate, Y and Kawamura, K and Sakiyama, S and Tagawa, M. (2001) Efficacy of the bystander effect in the herpes simplex virus thymidine kinase-mediated gene therapy is influenced by the expression of connexin43 in the target cells Cancer Gene Ther, 8, pp. 414-420. [PUBMED] [CSA]
32. Naus, C and Elisevich, K and Zhu, D and Belliveau, D and Del Maestro, R. (1992) In vivo growth of C6 glioma cells transfected with connexin43 cDNA Cancer Res, 52, pp. 4208-4213. [PUBMED] [CSA]
33. Nicholas, T and Read, S and Burrows, F and Kruse, C. (2003) Suicide gene therapy with Herpes simplex virus thymidine kinase and ganciclovir is enhanced with connexins to improve gap junctions and bystander effects Histol Histopathol, 18, pp. 495-507. [PUBMED] [CSA]
34. Nicholson, B and Weber, P and Cao, F and Chang, H and Lampe, P and Goldberg, G. (2000) The molecular basis of selective permeability of connexins is complex and includes both size and charge Braz J Med Biol Res, 33, pp. 369-378. [PUBMED] [CSA]
35. Ohgaki, H and Kleihues, P. (2005) Epidemiology and etiology of gliomas Acta Neuropathol (Berl), 109, pp. 93-108. [CSA]
36. Paquin, A and Jaalouk, D and Galipeau, J. (2001) Retrovector encoding a green fluorescent protein-herpes simplex virus thymidine kinase fusion protein serves as a versatile suicide/reporter for cell and gene therapy applications Hum Gene Ther, 12, pp. 13-23. [PUBMED] [CSA]
37. Park, J and Elshami, A and Amin, K and Rizk, N and Kaiser, L and Albelda, S. (1997) Retinoids augment the bystander effect in vitro and in vivo in herpes simplex virus thymidine kinase/ganciclovir-mediated gene therapy Gene Ther, 4, pp. 909-917. [PUBMED] [CSA]
38. Princen, F and Robe, P and Gros, D and Jarry-Guichard, T and Gielen, J and Merville, M and Bours, V. (2001) Rat gap junction connexin-30 inhibits proliferation of glioma cell lines Carcinogenesis, 22, pp. 507-513. [PUBMED] [CSA]
39. Pu, P and Xia, Z and Yu, S and Huang, Q. (2004) Altered expression of Cx43 in astrocytic tumors Clin Neurol Neurosurg, 107, pp. 49-54. [PUBMED] [CSA]
40. Qin, H and Shao, Q and Curtis, H and Galipeau, J and Belliveau, D and Wang, T and Alaoui-Jamali, M and Laird, D. (2002) Retroviral delivery of connexin genes to human breast tumor cells inhibits in vivo tumor growth by a mechanism that is independent of significant gap junctional intercellular communication J Biol Chem, 277, pp. 29132-29138. [PUBMED] [CSA]
41. Rainov, N and Ren, H. (2003) Clinical trials with retrovirus mediated gene therapy: What have we learned? J Neurooncol, 65, pp. 227-236. [PUBMED] [CSA]
42. Robe, P and Jolois, O and N'Guyen, M and Princen, F and Malgrange, B and Merville, M and Bours, V. (2004) Modulation of the HSV-TK/ganciclovir bystander effect by n-butyrate in glioblastoma: Correlation with gap-junction intercellular communication Int J Oncol, 25, pp. 187-192. [PUBMED] [CSA]
43. Rubsam, L and Boucher, P and Murphy, P and KuKuruga, M and Shewach, D. (1999) cytotoxicity and accumulation of ganciclovir triphosphate in bystander cells cocultured with herpes simplex virus type 1 thymidine kinase-expressing human glioblastoma cells Cancer Res, 59, pp. 669-675. [PUBMED] [CSA]
44. Sanson, M and Marcaud, V and Robin, E and Valery, C and Sturtz, F and Zalc, B. (2002) Connexin 43-mediated bystander effect in two rat glioma cell models Cancer Gene Ther, 9, pp. 149-155. [PUBMED] [CSA]
45. Shinoura, N and Chen, L and Wani, M and Kim, Y and Larson, J and Warnick, R and Simon, M and Menon, A and Bi, W and Stambrook, P. (1996) Protein and messenger RNA expression of connexin43 in astrocytomas: Implications in brain tumor gene therapy J Neurosurg, 84, pp. 839-845.discussion 846, [PUBMED] [CSA]
46. Smythe, W. (2000) Prodrug/drug sensitivity gene therapy: Current status Current Oncol Rep, 2, pp. 17-22. [CSA]
47. Sohl, G and Willecke, K. (2003) An update on connexin genes and their nomenclature in mouse and man Cell Commun Adhes, 10, pp. 173-180. [PUBMED] [CSA]
48. Sturtz, F and Waddell, K and Shulok, J and Chen, X and Caruso, M and Sanson, M and Snodgrass, H and Platika, D. (1997) Variable efficiency of the thymidine kinase/ganciclovir system in human glioblastoma cell lines: Implications for gene therapy Hum Gene Ther, 8, pp. 1945-1953. [PUBMED] [CSA]
49. Tanaka, T and Yamasaki, H and Mesnil, M. (2001a) Stimulation of intercellular communication of poor-communicating cells by gap-junction-competent cells enhances the HSV-TK/GCV bystander effect in vitro Int J Cancer, 91, pp. 538-542. [PUBMED] [CSA]
50. Tanaka, T and Yamasaki, H and Mesnil, M. (2001b) Induction of a bystander effect in HeLa cells by using a bigenic vector carrying viral thymidine kinase and connexin32 genes Mol Carcinog, 30, pp. 176-180. [PUBMED] [CSA]
51. Tong, X and Engehausen, D and Kaufman, R and Agoulnik, I and Contant, C and Freund, C and Oehler, M and Kim, T and Hasenburg, A and Woo, S and Kieback, D. (1998) Improvement of gene therapy for ovarian cancer by using acyclovir instead of ganciclovir in adenovirus mediated thymidine kinase gene therapy Anticancer Res, 18, pp. 713-718. [PUBMED] [CSA]
52. Vitaz, T and Warnke, P and Tabar, V and Gutin, P. (2005) Brachytherapy for brain tumors J Neurooncol, 73, pp. 71-86. [PUBMED] [CSA]
53. Vrionis, F and Wu, J and Qi, P and Waltzman, M and Cherington, V and Spray, D. (1997) The bystander effect exerted by tumor cells expressing the herpes simplex virus thymidine kinase (HSVtk) gene is dependent on connexin expression and cell communication via gap junctions Gene Ther, 4, pp. 577-585. [PUBMED] [CSA]
54. Yamasaki, H and Naus, C. (1996) Role of connexin genes in growth control Carcinogenesis, 17, pp. 1199-1213. [PUBMED] [CSA]
55. Yano, T and Hernandez-Blazquez, F and Omori, Y and Yamasaki, H. (2001) Reduction of malignant phenotype of HEPG2 cell is associated with the expression of connexin 26 but not connexin 32 Carcinogenesis, 22, pp. 1593-1600. [PUBMED] [CSA]
56. Zhu, D and Caveney, S and Kidder, G and Naus, C. (1991) Transfection of C6 glioma cells with connexin 43 cDNA: Analysis of expression, intercellular coupling, and cell proliferation Proc Natl Acad Sci USA, 88, pp. 1883-1887. [PUBMED] [CSA]